List view / Grid view

Staphylococcus aureus (S. aureus)



Antibiotics: resist the resistance

15 September 2016 | By Niamh Louise Marriott, Digital Content Producer

European Pharmaceutical Review caught up with Destiny Pharma’s CEO, Dr Love, for an exclusive interview to discuss why the pharmaceutical industry needs to radically change its approach to antibiotics in order to combat the threat of bacterial resistance…


FDA approves label update for Teflaro

2 September 2015 | By Victoria White

Teflaro is now approved for the treatment of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia...